Key features and details
- Potent, selective, irreversible and cell-permeable 20S proteasome inhibitor
- CAS Number: 134381-21-8
- Purity: > 97%
- Soluble in DMSO to 10 mM
- Form / State: Solid
- Source: Actinomyces sp.
Product nameEpoxomicin, 20S proteasome inhibitor
DescriptionPotent, selective, irreversible and cell-permeable 20S proteasome inhibitor
Biological descriptionPotent, selective, irreversible and cell-permeable 20S proteasome inhibitor (IC50 = 4 nM). Predominantly inhibits the chymotrypsin-like activity. Anti-inflammatory and antitumor agent. Active in vitro and in vivo.
Storage instructionsStore at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.
Solubility overviewSoluble in DMSO to 10 mM
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one week. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab144598 has been referenced in 3 publications.
- Cassioli C et al. The Bardet-Biedl syndrome complex component BBS1 controls T cell polarity during immune synapse assembly. J Cell Sci 134:N/A (2021). PubMed: 34423835
- Ren D et al. Wnt5a induces and maintains prostate cancer cells dormancy in bone. J Exp Med 216:428-449 (2019). PubMed: 30593464
- Onnis A et al. The pro-oxidant adaptor p66SHC promotes B cell mitophagy by disrupting mitochondrial integrity and recruiting LC3-II. Autophagy 14:2117-2138 (2018). PubMed: 30109811